Beacon Pointe Advisors LLC Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Beacon Pointe Advisors LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 59,105 shares of the healthcare conglomerate's stock after selling 4,251 shares during the quarter. Beacon Pointe Advisors LLC's holdings in UnitedHealth Group were worth $29,899,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Sugarloaf Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after purchasing an additional 1,193 shares during the period. Signal Advisors Wealth LLC boosted its holdings in shares of UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after buying an additional 1,051 shares in the last quarter. Waycross Partners LLC boosted its stake in UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after acquiring an additional 658 shares in the last quarter. Czech National Bank increased its stake in shares of UnitedHealth Group by 6.1% during the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock valued at $100,937,000 after purchasing an additional 11,426 shares in the last quarter. Finally, Lmcg Investments LLC boosted its position in shares of UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock worth $19,210,000 after purchasing an additional 4,022 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $2.24 during trading on Friday, reaching $398.45. The company had a trading volume of 7,547,223 shares, compared to its average volume of 4,583,993. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm's 50-day simple moving average is $497.29 and its 200 day simple moving average is $529.82. The firm has a market capitalization of $362.67 billion, a price-to-earnings ratio of 25.70, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $393.31 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm posted $6.91 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. UnitedHealth Group's dividend payout ratio is presently 35.18%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. HSBC restated a "hold" rating and set a $490.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Mizuho upped their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Finally, Oppenheimer decreased their price target on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research note on Monday, April 21st. Three analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.